Both in Pharmaceuticals
Indaptus Therapeutics vs Relmada Therapeutics
Over the past year INDP returned +3.8% and RLMD returned +94.1%; their daily moves had a correlation of 0.04.
INDP +3.8% RLMD +94.1%Growth of $1, one year, split-adjusted
| Metric | INDP | RLMD |
|---|---|---|
| Price | $3.24 | $4.27 |
| Market cap | $431.7M | $455.5M |
| Today | −7.43% | +11.20% |
| 1 month | +29.1% | +22.7% |
| 6 months | +55.0% | −41.9% |
| Year to date | +11.3% | −11.6% |
| 1 year | +0.6% | +88.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.6M | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | 193.5% | 59.9% |
| Short % of float | 7.4% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).